- Main
Recommendations for clinical implementation of blood-based biomarkers for Alzheimers disease.
- Mielke, Michelle;
- Anderson, Matthew;
- Ashford, J;
- Jeromin, Andreas;
- Lin, Pei-Jung;
- Rosen, Allyson;
- Tyrone, Jamie;
- Vandevrede, Lawren;
- Willis, Deanna;
- Hansson, Oskar;
- Khachaturian, Ara;
- Schindler, Suzanne;
- Weiss, Joan;
- Batrla, Richard;
- Bozeat, Sasha;
- Dwyer, John;
- Holzapfel, Drew;
- Jones, Daryl;
- Murray, James;
- Partrick, Katherine;
- Scholler, Emily;
- Vradenburg, George;
- Young, Dylan;
- Braunstein, Joel;
- Burnham, Samantha;
- de Oliveira, Fabricio;
- Hu, Yan;
- Mattke, Soeren;
- Merali, Zul;
- Monane, Mark;
- Sabbagh, Marwan;
- Shobin, Eli;
- Weiner, Michael;
- Udeh-Momoh, Chinedu
Published Web Location
https://doi.org/10.1002/alz.14184Abstract
Blood-based biomarkers (BBM) for Alzheimers disease (AD) are being increasingly used in clinical practice to support an AD diagnosis. In contrast to traditional diagnostic modalities, such as amyloid positron emission tomography and cerebrospinal fluid biomarkers, BBMs offer a more accessible and lower cost alternative for AD biomarker testing. Their unique scalability addresses the anticipated surge in demand for biomarker testing with the emergence of disease-modifying treatments (DMTs) that require confirmation of amyloid pathology. To facilitate the uptake of BBMs in clinical practice, The Global CEO Initiative on Alzheimers Disease convened a BBM Workgroup to provide recommendations for two clinical implementational pathways for BBMs: one for current use for triaging and another for future use to confirm amyloid pathology. These pathways provide a standardized diagnostic approach with guidance on interpreting BBM test results. Integrating BBMs into clinical practice will simplify the diagnostic process and facilitate timely access to DMTs for eligible patients.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.
Main Content
Enter the password to open this PDF file:
-
-
-
-
-
-
-
-
-
-
-
-
-
-